Jiangxi Fushine Pharmaceutical (300497.SZ) Earnings Analysis

Jiangxi Fushine Pharmaceutical (300497.SZ) has no confirmed upcoming earnings date. Trailing P/E -95.07.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 300497.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 300497.SZ. This page updates as the calendar is published.

300497.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-230.11 CNYn/an/an/a
2025-06-30-0.01635 CNYn/an/an/a
2025-04-280.004 CNYn/an/an/a
2025-04-25-0.38423 CNYn/an/an/a
2024-08-28-0.04442 CNYn/an/an/a

300497.SZ valuation and analyst view

Trailing P/E-95.07
Trailing EPS0.00732 CNY
Price / book4.19
Dividend yield0.00%
Market cap8.76B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Jiangxi Fushine Pharmaceutical (300497.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 300497.SZ. This page updates as the calendar is published.

Did 300497.SZ beat earnings last quarter?

Consensus estimate data was not available for 300497.SZ's 2026-04-23 report.

What is 300497.SZ's current P/E ratio and EPS?

300497.SZ trades at a trailing P/E of -95.07 on trailing EPS of 0.007323269633555801 CNY.

What do analysts rate 300497.SZ?

300497.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.